Development of Receptor-Selective Opioid Peptide Analogs as Pharmacologic Tools and as Potential Drugs
- 1 January 1993
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: Development of a ligard with high delta opioid receptor selectivity and affinityLife Sciences, 1988
- A preliminary study of the pharmacodynamics and pharmacokinetics of a novel enkephalin analogue [Tyr-D.Arg-Gly-Phe(4NO2)·Pro·NH2 (BW443C)] in healthy volunteersEuropean Journal of Clinical Pharmacology, 1988
- A novel cyclic opioid peptide analog showing high preference for μ-receptorsBiochemical and Biophysical Research Communications, 1985
- Comparison of μ-, δ- and κ-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptidesLife Sciences, 1983
- Human tolerability studies with D-Met2, Pro5-enkephalinamideLife Sciences, 1983
- Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivityLife Sciences, 1983
- [D-Pen2, L-cys5]enkephalinamide and [D-pen2, D-cys5]enkephalinamide, conformationally constrained cyclic enkephalinamide analogs with delta receptor specificityBiochemical and Biophysical Research Communications, 1982
- Cyclic enkephalin analogs containing a cystine bridgeBiochemical and Biophysical Research Communications, 1981
- Selective receptors for β-endorphin on the rat vas deferensLife Sciences, 1979
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973